Pycnogenol for the Treatment of Lymphedema
Status: | Completed |
---|---|
Conditions: | Breast Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | May 2002 |
End Date: | January 2007 |
Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo
The objectives of this study are to evaluate the effectiveness of Pycnogenol (French
maritime pine bark extract) for arm lymphedema in women following treatment for breast
cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement
of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life
questionnaire.
maritime pine bark extract) for arm lymphedema in women following treatment for breast
cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement
of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life
questionnaire.
Inclusion Criteria:
- > 6 months from last surgical and/or radiation treatment to the affected axilla
- Unilateral lymphedema of the upper extremity
Exclusion Criteria:
- May not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy
treatment while on this study
We found this trial at
1
site
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
Click here to add this to my saved trials